NASDAQ:NDRA ENDRA Life Sciences (NDRA) Stock Price, News & Analysis $0.45 -0.21 (-31.96%) (As of 08/21/2024 ET) Add Compare Share Share Today's Range$0.43▼$0.5750-Day Range$0.03▼$347.5052-Week Range$0.43▼$139.50Volume10.58 million shsAverage Volume309,404 shsMarket Capitalization$32.44 millionP/E RatioN/ADividend YieldN/APrice Target$20,000.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends Get ENDRA Life Sciences alerts: Email Address ENDRA Life Sciences MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside4,474,172.9% Upside$20,000.00 Price TargetShort InterestHealthy0.30% of Shares Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment-0.17Based on 8 Articles This WeekInsider TradingN/AProj. Earnings GrowthN/ASee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.11 out of 5 starsMedical Sector556th out of 924 stocksElectromedical Equipment Industry11th out of 21 stocks 3.5 Analyst's Opinion Consensus RatingENDRA Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageENDRA Life Sciences has only been the subject of 1 research reports in the past 90 days.Read more about ENDRA Life Sciences' stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.30% of the outstanding shares of ENDRA Life Sciences have been sold short.Short Interest Ratio / Days to CoverENDRA Life Sciences has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in ENDRA Life Sciences has recently decreased by 5.86%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldENDRA Life Sciences does not currently pay a dividend.Dividend GrowthENDRA Life Sciences does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for NDRA. Previous Next 1.6 News and Social Media Coverage News SentimentENDRA Life Sciences has a news sentiment score of -0.17. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.44 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 8 news articles for ENDRA Life Sciences this week, compared to 1 article on an average week.Search Interest23 people have searched for NDRA on MarketBeat in the last 30 days. This is an increase of 92% compared to the previous 30 days.MarketBeat FollowsOnly 8 people have added ENDRA Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, ENDRA Life Sciences insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 0.71% of the stock of ENDRA Life Sciences is held by insiders.Percentage Held by InstitutionsOnly 1.19% of the stock of ENDRA Life Sciences is held by institutions.Read more about ENDRA Life Sciences' insider trading history. Previous Next 0.6 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of ENDRA Life Sciences is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of ENDRA Life Sciences is -0.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioENDRA Life Sciences has a P/B Ratio of 0.67. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about ENDRA Life Sciences' valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad DTI3 dividend stocks to ownThe “Income Ace” Jack Carter just revealed his entire dividend strategy. Including 3 specific tickers to consider owning. And his “golden rules” for trading dividend stocks. These aren’t just theoretical rules, either. Jack revealed that the vast majority of his income capital is deployed in this straightforward portfolio of dividend stocks.Watch this presentation asap. About ENDRA Life Sciences Stock (NASDAQ:NDRA)ENDRA Life Sciences Inc. develops technologies to improve the capabilities of clinical diagnostic ultrasound. The company is developing thermo-acoustic enhanced ultrasound technology that uses radio frequency pulses to generate ultrasonic waves in tissue to create high-contrast images for use in the treatment of nonalcoholic fatty liver disease, as well as in tissue composition, temperature monitoring, vascular imaging, and tissue perfusion. It has a collaborative research agreement with General Electric Company. ENDRA Life Sciences Inc. was incorporated in 2007 and is based in Ann Arbor, Michigan.Read More NDRA Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NDRA Stock News HeadlinesAugust 20 at 2:27 AM | americanbankingnews.comENDRA Life Sciences (NDRA) Set to Announce Earnings on ThursdayAugust 18, 2024 | americanbankingnews.comENDRA Life Sciences Shares to Reverse Split on Tuesday, August 20th (NASDAQ:NDRA)August 22, 2024 | DTI (Ad)I never thought I would do this…Now that the Fed has spoken, it’s sure to create a May Shockwave! Now's your best chance to trade this historic event using the method that has seen Doubles, Even Triples within just a few days! You see, while most folks will be paying $500… $1,000… or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options in a volatile market. You see, by entering on certain predetermined dates, we have been able to watch as these $0.25 Cent Trades doubled, even tripled in what feels like no time.August 17, 2024 | yahoo.comFrederick County unveils road map to expand life sciencesAugust 17, 2024 | stockhouse.comENDRA Life Sciences Announces Reverse Stock SplitAugust 15, 2024 | markets.businessinsider.comBuy Rating Affirmed for Kezar Life Sciences Amidst Strong Clinical Progress and Strategic FocusAugust 15, 2024 | markets.businessinsider.comeLabNext and US Lab Partners Enhance Digital Infrastructure for Life Science CompaniesAugust 12, 2024 | americanbankingnews.comENDRA Life Sciences (NDRA) Scheduled to Post Quarterly Earnings on WednesdayAugust 22, 2024 | DTI (Ad)I never thought I would do this…Now that the Fed has spoken, it’s sure to create a May Shockwave! Now's your best chance to trade this historic event using the method that has seen Doubles, Even Triples within just a few days! You see, while most folks will be paying $500… $1,000… or even MORE to trade popular stocks like Apple, Nvidia, or Microsoft… I’ve discovered a new way to tap into what could be the cheapest options in a volatile market. You see, by entering on certain predetermined dates, we have been able to watch as these $0.25 Cent Trades doubled, even tripled in what feels like no time.August 7, 2024 | bizjournals.comLife-sciences vacancy rate ticks up as new supply outweighs demandAugust 7, 2024 | finance.yahoo.comENDRA Life Sciences to Report Second Quarter 2024 Financial Results on August 14July 25, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Edwards Lifesciences (EW) and Tenet Healthcare (THC)July 25, 2024 | reuters.comIndia's Glenmark Life Sciences posts higher Q1 revenue on API boostJuly 20, 2024 | nasdaq.comENDRA Life Sciences Inc. Common Stock (NDRA)June 17, 2024 | investorplace.comWhy Is ENDRA Life Sciences (NDRA) Stock Up 36% Today?June 4, 2024 | businesswire.comENDRA Life Sciences Announces Pricing of $8.0 Million Public OfferingMay 22, 2024 | uk.investing.comENDRA meets with FDA on liver device clinical trial designMay 21, 2024 | msn.comR.I. will issue $80m bond for URI life sciences building this year, Speaker Shekarchi saysSee More Headlines Receive NDRA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings8/14/2024Today8/22/2024Next Earnings (Estimated)11/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Electromedical equipment Sub-IndustryMedical Equipment Current SymbolNASDAQ:NDRA CUSIPN/A CIK1681682 Webwww.endrainc.com Phone(734) 335-0468FaxN/AEmployees20Year FoundedN/APrice Target and Rating Average Stock Price Target$20,000.00 High Stock Price Target$20,000.00 Low Stock Price Target$20,000.00 Potential Upside/Downside+4,474,172.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($1.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,060,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-204.78% Return on Assets-153.48% Debt Debt-to-Equity RatioN/A Current Ratio1.04 Quick Ratio1.04 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.67 per share Price / Book0.67Miscellaneous Outstanding Shares72,574,000Free Float72,059,000Market Cap$32.44 million OptionableNot Optionable Beta0.82 7 Stocks to Buy And Hold ForeverClick the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising. Get This Free Report Key ExecutivesMr. Francois Michelon (Age 58)Chairman, President & CEO Comp: $388.45kMs. Irina Pestrikova (Age 37)Senior Director of Finance & Secretary Comp: $185kMr. Michael Thornton Ph.D. (Age 56)Chief Technology Officer Comp: $279.24kDr. Jonathan Behr Ph.D.Co-FounderMr. Steve FreemanHuman Resources LeaderKey CompetitorsNuwellisNASDAQ:CHFSCVRxNASDAQ:CVRXBeauty HealthNASDAQ:SKINLakeland IndustriesNASDAQ:LAKEEdap TmsNASDAQ:EDAPView All Competitors NDRA Stock Analysis - Frequently Asked Questions How have NDRA shares performed this year? ENDRA Life Sciences' stock was trading at $5,300.00 on January 1st, 2024. Since then, NDRA shares have decreased by 100.0% and is now trading at $0.4470. View the best growth stocks for 2024 here. How were ENDRA Life Sciences' earnings last quarter? ENDRA Life Sciences Inc. (NASDAQ:NDRA) announced its earnings results on Wednesday, August, 14th. The company reported ($4.00) earnings per share for the quarter, missing the consensus estimate of ($3.50) by $0.50. When did ENDRA Life Sciences' stock split? Shares of ENDRA Life Sciences reverse split before market open on Tuesday, August 20th 2024. The 1-50 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. When did ENDRA Life Sciences IPO? ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering (IPO) on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO. How do I buy shares of ENDRA Life Sciences? Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of ENDRA Life Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that ENDRA Life Sciences investors own include Advanced Micro Devices (AMD), Trevena (TRVN), VBI Vaccines (VBIV), Bionano Genomics (BNGO), OPKO Health (OPK) and TherapeuticsMD (TXMD). This page (NASDAQ:NDRA) was last updated on 8/22/2024 by MarketBeat.com Staff From Our PartnersWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAir Force quietly working with sub $10 stock on new techThere is a little-known energy technology stock that has made an incredible breakthrough… Which could becom...DTI | SponsoredGrab this ETF paying a huge 22% dividendImagine a world where you don't have to stress about inflation eroding your savings... Where your paycheck ...Investors Alley | SponsoredAmazon coin set to soar 25X – starting August 19thChris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...True Market Insiders | Sponsored625,000% GainThe recent crypto pullback has been brutal, causing widespread panic among investors. But for us, it’s just an...Crypto Swap Profits | SponsoredAlex's "Next Magnificent Seven" StocksToday Alex Green is releasing his new breakdown of AI's "Next Magnificent Seven." So please make some time ...The Oxford Club | SponsoredThe #1 A.I. Crypto You Don’t Own (YET!)Markets are volatile right now—stocks, cryptos, you name it. But here's a crucial fact everyone is missing:...Crypto 101 Media | SponsoredYou’ve been lied to for 615 days, and countingAll of the hype around artificial intelligence has been nothing but an artificial illusion…Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ENDRA Life Sciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share ENDRA Life Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
